The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
SMYD3 encodes a histone methyltransferase involved in the proliferation of cancer cells
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Jenuwein, T., & Allis, C. D. (2001) · Science · doi:10.1126/science.1063127 · Cited by 9,756
The language of covalent histone modifications
Strahl, B. D., & Allis, C. D. (2000) · Nature · doi:10.1038/47412 · Cited by 8,679
Parkin, D. M., Pisani, P., & Ferlay, J. (1999) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.49.1.33 · Cited by 3,376
Regulation of chromatin structure by site-specific histone H3 methyltransferases
Rea, S., Eisenhaber, F., O'Carroll, D., Strahl, B. D., Sun, Z.-W., Schmid, M., Opravil, S., Mechtler, K., Ponting, C. P., Allis, C. D., et al. (2000) · Nature · doi:10.1038/35020506 · Cited by 2,845 · cited 1×
“The increasing knowledge of histone methylation suggests that methylation of lysine 9 in histone H3 (H3-K9) is involved in transcriptionally-repressive heterochromatin formation with heterochromatin-associated protein”
BackgroundThe polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Active Genes Are Tri-Methylated at K4 of Histone H3
Santos-Rosa, H., Schneider, R., Bannister, A. J., Sherriff, J., Bernstein, B. E., Emre, N. C. T., Schreiber, S. L., Mellor, J., & Kouzarides, T. (2002) · Nature · doi:10.1038/nature01080 · Cited by 2,138
Histone deacetylases and cancer: causes and therapies
Marks, P. A., Rifkind, R. A., Richon, V. M., Breslow, R., Miller, T., & Kelly, W. K. (2001) · Nature reviews. Cancer · doi:10.1038/35106079 · Cited by 1,866
Loss of the Suv39h Histone Methyltransferases Impairs Mammalian Heterochromatin and Genome Stability
Peters, A. H. F. M., O'Carroll, D., Scherthan, H., Mechtler, K., Sauer, S., Schöfer, C., Weipoltshammer, K., Pagani, M., Lachner, M., Kohlmaier, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00542-6 · Cited by 1,766
Zhang, Y., & Reinberg, D. (2001) · Genes & Development · doi:10.1101/gad.927301 · Cited by 1,530
EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.
Bracken, A. P., Pasini, D., Capra, M., Prosperini, E., Colli, E., & Helin, K. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg542 · Cited by 1,196
Ng, H. H., Robert, F., Young, R. A., & Struhl, K. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00092-3 · Cited by 1,095
MLL Targets SET Domain Methyltransferase Activity to Hox Gene Promoters
Milne, T. A., Briggs, S. D., Brock, H. W., Martin, M. E., Gibbs, D., Allis, C. D., & Hess, J. L. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00741-4 · Cited by 1,053
Histone methylation in transcriptional control
Kouzarides, T. (2002) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(02)00287-3 · Cited by 908
The many faces of histone lysine methylation
Lachner, M., & Jenuwein, T. (2002) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(02)00335-6 · Cited by 819
Histone H3 lysine 4 methylation patterns in higher eukaryotic genes
Schneider, R., Bannister, A. J., Myers, F. A., Thorne, A. W., Crane-Robinson, C., & Kouzarides, T. (2004) · Nature Cell Biology · doi:10.1038/ncb1076 · Cited by 792
Tachibana, M., Sugimoto, K., Fukushima, T., & Shinkai, Y. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101914200 · Cited by 784
Nakamura, T., Mori, T., Tada, S., Krajewski, W., Rozovskaia, T., Wassell, R., Dubois, G., Mazo, A., Croce, C. M., & Canaani, E. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00740-2 · Cited by 721
Krogan, N. J., Dover, J., Wood, A., Schneider, J., Heidt, J., Boateng, M. A., Dean, K., Ryan, O. W., Golshani, A., Johnston, M., et al. (2003) · Molecular Cell · doi:10.1016/s1097-2765(03)00091-1 · Cited by 714
Okabe, H., Satoh, S., Kato, T., Kitahara, O., Yanagawa, R., Yamaoka, Y., Tsunoda, T., Furukawa, Y., & Nakamura, Y. (2001) · PubMed · Cited by 546
Self-citationPurification and Functional Characterization of a Histone H3-Lysine 4-Specific Methyltransferase
Wang, H., Cao, R., Xia, L., Erdjument-Bromage, H., Borchers, C., Tempst, P., & Zhang, Y. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00405-1 · Cited by 538
Bebbington, P. (2001) · Social Psychiatry and Psychiatric Epidemiology · doi:10.1007/s001270170010 · Cited by 513
Strahl, B. D., Ohba, R., Cook, R. G., & Allis, C. D. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.14967 · Cited by 491
Li, J., Moazed, D., & Gygi, S. P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m209294200 · Cited by 272
Histone acetylation and cancer
Archer, S. Y., & Hodint, R. A. (1999) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(99)80026-4 · Cited by 261
Dimerization contributes to oncogenic activation of MLL chimeras in acute leukemias
So, C. W., Lin, M., Ayton, P. M., Chen, E. H., & Cleary, M. L. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00188-0 · Cited by 196
Lin, Y.-M., Furukawa, Y., Tsunoda, T., Yue, C.-T., Yang, K.-C., & Nakamura, Y. (2002) · Oncogene · doi:10.1038/sj.onc.1205518 · Cited by 190
Self-citationShimokawa, T., Furukawa, Y., Sakai, M., Li, M., Miwa, N., Lin, Y., & Nakamura, Y. (2003) · PubMed · Cited by 185
Self-citationSET domains and histone methylation
Xiao, B., Wilson, J. R., & Gamblin, S. J. (2003) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2003.10.003 · Cited by 163
Involvement of PEG10 in human hepatocellular carcinogenesis through interaction with SIAH1.
Okabe, H., Satoh, S., Furukawa, Y., Kato, T., Hasegawa, S., Nakajima, Y., Yamaoka, Y., & Nakamura, Y. (2003) · PubMed · Cited by 163
Self-citationDelwel, R., Funabiki, T., Kreider, B. L., Morishita, K., & Ihle, J. N. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.7.4291-4300.1993 · Cited by 128
Mechanism of histone lysine methyl transfer revealed by the structure of SET7/9—AdoMet
Kwon, T., Chang, J. H., Kwak, E., Lee, C. W., Joachimiak, A., Kim, Y. C., Lee, J. W., & Cho, Y. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg025 · Cited by 128
Huntsman, D. D., Chin, S., Muleris, M., Batley, S. J., Collins, V. P., Wiedemann, L. M., Aparicio, S. A. J. R., & Caldas, C. (1999) · Oncogene · doi:10.1038/sj.onc.1203291 · Cited by 107
Apergis, G. A., Crawford, N., Ghosh, D., Steppan, C. M., Vorachek, W. R., Wen, P., & Locker, J. D. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.5.2917 · Cited by 56
Tang, C.-J. C., Chuang, C.-K., Hu, H., & Tang, T. K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100170200 · Cited by 38
Cited by
Histone demethylation mediated by the nuclear amine oxidase homolog LSD1
Shi, Y., Lan, F., Matson, C., Mulligan, P., Whetstine, J. R., Cole, P. A., Casero, R. A., & Shi, Y. (2004) · Cell · doi:10.1016/j.cell.2004.12.012 · Cited by 4,051
Epigenetic modifications and human disease
Portela, A., & Esteller, M. (2010) · Nature Biotechnology · doi:10.1038/nbt.1685 · Cited by 2,836
Histone methylation: a dynamic mark in health, disease and inheritance
Greer, E. L., & Shi, Y. (2012) · Nature Reviews Genetics · doi:10.1038/nrg3173 · Cited by 2,241
The epigenetic progenitor origin of human cancer
Feinberg, A. P., Ohlsson, R., & Henikoff, S. (2006) · Nature Reviews Genetics · doi:10.1038/nrg1748 · Cited by 1,853
Targeting the dynamic HSP90 complex in cancer
Trepel, J., Mollapour, M., Giaccone, G., & Neckers, L. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2887 · Cited by 1,514
Metadata
- Authors
- Hamamoto, R., Furukawa, Y., Morita, M., Iimura, Y., Silva, F. P., Li, M., Yagyu, R., & Nakamura, Y.
- Venue
- Nature Cell Biology
- Published
- 2004-07-04
- Volume
- 6
- Issue
- 8
- Pages
- 731-740
- ISSN
- 1465-7392 (ISSN-L)
- 1476-4679
- OpenAlex
- W2146634563
- Cited by
- 731
- References
- 35
- FWCI
- 9.62
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.